Douglas Earl Martin

EDGAR CIK 0001362155

Allogene Therapeutics, Inc. - ALLO

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Officer
SVP, General Counsel
Direct Buys
0
$0
0 Shares
Direct Sells
1
($40,304)
-22,900 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
02/02/2026
02/04/2026
Sell
-22,900 @ $1.76
 ($40,304) 564,948 (-3.90%) Direct